$LLY
ELI LILLY & Co Stock $lly

$lly Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000005947822000133 Filed on April 29, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$7.810B	$8.000B	$6.806B
YoY Change	14.76%	7.53%	16.14%
Cost Of Revenue	$2.072B	$2.050B	$1.879B
YoY Change	10.3%	19.21%	54.6%
Gross Profit	$5.738B	$5.950B	$4.927B
YoY Change	16.46%	4.01%	6.08%
Gross Profit Margin	73.47%	74.37%	72.4%
Selling, General & Admin	$1.558B	$1.592B	$1.576B
YoY Change	-1.15%	2.45%	1.7%
% of Gross Profit	27.15%	26.76%	31.99%
Research & Development	$1.610B	$1.959B	$1.672B
YoY Change	-3.71%	6.61%	20.11%
% of Gross Profit	28.06%	32.93%	33.94%
Depreciation & Amortization	$435.7M	$445.7M	$350.3M
YoY Change	24.38%	21.28%	28.03%
% of Gross Profit	7.59%	7.49%	7.11%
Operating Expenses	$3.168B	$3.551B	$3.248B
YoY Change	-2.47%	4.7%	10.42%
Operating Profit	$2.570B	$2.398B	$1.679B
YoY Change	53.07%	3.01%	-1.42%
Interest Expense	$84.90M	-$167.2M	$87.80M
YoY Change	-3.3%	100.48%	-5.08%
% of Operating Profit	3.3%	-6.97%	5.23%
Other Income/Expense, Net	-$350.7M	$89.90M	$321.1M
YoY Change	-209.22%	-83.96%	260.38%
Pretax Income	$2.054B	$1.840B	$1.476B
YoY Change	39.1%	-25.48%	-12.11%
Income Tax	$150.7M	$113.8M	$121.1M
% Of Pretax Income	7.34%	6.19%	8.2%
Net Earnings	$1.903B	$1.726B	$1.355B
YoY Change	40.4%	-18.46%	-6.95%
Net Earnings / Revenue	24.36%	21.58%	19.91%
Basic Earnings Per Share	$2.11		$1.49
Diluted Earnings Per Share	$2.10	$1.893M	$1.49
COMMON SHARES
Basic Shares Outstanding	903.7M shares	956.6M shares	908.8M shares
Diluted Shares Outstanding	906.4M shares		912.4M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.568B	$3.909B	$3.051B
YoY Change	-15.82%	6.18%	71.69%
Cash & Equivalents	$2.459B	$3.819B	$3.002B
Short-Term Investments	$109.1M	$90.10M	$49.00M
Other Short-Term Assets	$2.698B	$2.531B	$3.234B
YoY Change	-16.58%	-11.89%	17.09%
Inventory	$3.893B	$3.886B	$3.661B
Prepaid Expenses	$2.698B	$2.531B	$3.234B
Receivables	$6.323B	$6.673B	$5.593B
Other Receivables	$1.483B	$1.454B	$1.066B
Total Short-Term Assets	$16.96B	$18.45B	$16.60B
YoY Change	2.17%	5.67%	18.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.103B	$8.985B	$8.630B
YoY Change	5.48%	3.49%	9.27%
Goodwill	$3.892B	$3.892B	$3.877B
YoY Change	0.38%	3.33%	2.6%
Intangibles	$7.482B	$7.692B	$8.088B
YoY Change	-7.49%	3.25%	4.13%
Long-Term Investments	$2.727B	$3.213B	$3.232B
YoY Change	-15.62%	8.28%	50.4%
Other Assets	$4.285B	$4.083B	$3.756B
YoY Change	14.09%	17.47%	23.37%
Total Long-Term Assets	$29.95B	$30.35B	$30.23B
YoY Change	-0.92%	4.05%	11.53%
TOTAL ASSETS
Total Short-Term Assets	$16.96B	$18.45B	$16.60B
Total Long-Term Assets	$29.95B	$30.35B	$30.23B
Total Assets	$46.92B	$48.81B	$46.84B
YoY Change	0.17%	4.66%	13.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.433B	$1.671B	$1.640B
YoY Change	-12.58%	3.98%	35.76%
Accrued Expenses	$693.1M	$958.1M	$650.0M
YoY Change	6.63%	-3.9%	14.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.356B	$1.538B	$5.000M
YoY Change	27018.0%	16992.22%	-99.85%
Total Short-Term Liabilities	$13.39B	$15.05B	$11.71B
YoY Change	14.27%	20.6%	-7.11%
LONG-TERM LIABILITIES
Long-Term Debt	$15.15B	$15.35B	$16.20B
YoY Change	-6.46%	-7.48%	15.86%
Other Long-Term Liabilities	$1.714B	$1.644B	$1.737B
YoY Change	-1.35%	-3.7%	-7.25%
Total Long-Term Liabilities	$24.07B	$24.60B	$28.02B
YoY Change	-14.11%	-13.16%	10.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.39B	$15.05B	$11.71B
Total Long-Term Liabilities	$24.07B	$24.60B	$28.02B
Total Liabilities	$37.46B	$39.65B	$39.74B
YoY Change	-5.74%	-2.83%	4.84%
SHAREHOLDERS EQUITY
Retained Earnings	$9.369B	$8.959B	$9.181B
YoY Change	2.05%	14.41%	56.16%
Common Stock	$7.250B	$7.430B	$7.179B
YoY Change	1.0%	0.72%	0.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$50.50M	$52.70M	$52.70M
YoY Change	-4.17%	-5.39%	-5.39%
Treasury Stock Shares
Shareholders Equity	$9.331B	$8.979B	$6.899B
YoY Change
Total Liabilities & Shareholders Equity	$46.92B	$48.81B	$46.84B
YoY Change	0.17%	4.66%	13.95%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	$1.903B	$1.726B	$1.355B
YoY Change	40.4%	-18.46%	-6.95%
Depreciation, Depletion And Amortization	$435.7M	$445.7M	$350.3M
YoY Change	24.38%	21.28%	28.03%
Cash From Operating Activities	$2.499B	$2.157B	$1.697B
YoY Change	47.24%	18.8%	343.88%
INVESTING ACTIVITIES
Capital Expenditures	-$857.2M	-$394.2M	-$492.1M
YoY Change	74.19%	-51.9%	81.39%
Acquisitions	$0.00		$747.4M
YoY Change	-100.0%		-12.0%
Other Investing Activities	$133.4M	$15.20M	$21.90M
YoY Change	509.13%	-89.55%	-142.61%
Cash From Investing Activities	-$1.014B	-$379.0M	-$1.284B
YoY Change	-21.01%	-43.78%	20.98%
FINANCING ACTIVITIES
Cash Dividend Paid	$885.5M		$774.8M
YoY Change	14.29%		15.42%
Common Stock Issuance & Retirement, Net	$1.500B		$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net	$710.1M		$0.00
YoY Change			-100.0%
Cash From Financing Activities	-$2.878B	-1.527B	-$1.058B
YoY Change	171.95%	18.2%	-1091.94%
NET CHANGE
Cash From Operating Activities	$2.499B	2.157B	$1.697B
Cash From Investing Activities	-$1.014B	-379.0M	-$1.284B
Cash From Financing Activities	-$2.878B	-1.527B	-$1.058B
Net Change In Cash	-$1.359B	251.0M	-$654.7M
YoY Change	107.62%	-266.89%	2.54%
FREE CASH FLOW
Cash From Operating Activities	$2.499B	$2.157B	$1.697B
Capital Expenditures	-$857.2M	-$394.2M	-$492.1M
Free Cash Flow	$3.356B	$2.551B	$2.190B
YoY Change	53.3%	-3.19%	234.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000059478
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-6351
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	ELI LILLY AND COMPANY
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IN
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-0470950
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Lilly Corporate Center
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Indianapolis
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46285
CY2022Q1	dei	City Area Code CityAreaCode	317
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	276-2000
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1878600000	USD
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	950159559	shares
CY2022Q1	us-gaap	Revenues Revenues	7810000000	USD
CY2021Q1	us-gaap	Revenues Revenues	6805600000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2072100000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1610100000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1672100000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1557900000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1576000000	USD
CY2022Q1	lly	Acquired In Process Research And Development And Development Milestones AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones	165600000	USD
CY2021Q1	lly	Acquired In Process Research And Development And Development Milestones AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones	312000000.0	USD
CY2022Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	0	USD
CY2021Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	211600000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-350700000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	321100000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	121100000	USD
CY2022Q1	lly	Cost Of Sales Operating Expenses And Other Net CostOfSalesOperatingExpensesAndOtherNet	5756400000	USD
CY2021Q1	lly	Cost Of Sales Operating Expenses And Other Net CostOfSalesOperatingExpensesAndOtherNet	5329200000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2053600000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1476400000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	150700000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1902900000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1355300000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.11
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.10
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	903700000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	908800000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	906400000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	912400000	shares
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	100800000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2020700000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	3893000000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1902900000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1355300000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	117800000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1456100000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2459200000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3818500000	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	109100000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	90100000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	22000000.0	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	22500000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6322500000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6672800000	USD
CY2022Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1483200000	USD
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1454400000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8985100000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	3886000000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2697700000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2530600000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	16964700000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	18452400000	USD
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	2727300000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	3212600000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	3892000000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	3892000000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7482400000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7691900000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2464900000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2489300000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10138300000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9976700000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9102700000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4285300000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4082700000	USD
CY2022Q1	us-gaap	Debt Current DebtCurrent	1355900000	USD
CY2022Q1	us-gaap	Assets Assets	46919300000	USD
CY2021Q4	us-gaap	Assets Assets	48806000000	USD
CY2021Q4	us-gaap	Debt Current DebtCurrent	1538300000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1433300000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1670600000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	693100000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	958100000	USD
CY2022Q1	lly	Sales Rebates And Discounts SalesRebatesAndDiscounts	6768700000	USD
CY2021Q4	lly	Sales Rebates And Discounts SalesRebatesAndDiscounts	6845800000	USD
CY2022Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	0	USD
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	885500000	USD
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	598300000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	126900000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2536700000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3027500000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	594100000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13386000000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15052700000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15152900000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15346400000	USD
CY2022Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	1940300000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	1954100000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3978100000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3920000000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1286100000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1733700000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1713900000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1644300000	USD
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	24071300000	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	24598500000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6833400000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	596300000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6656300000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9369400000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8958500000	USD
CY2022Q1	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	3013200000	USD
CY2021Q4	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	3013200000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4225300000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4343100000	USD
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	50500000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	52700000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	9330800000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8979200000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	131200000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	175600000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9462000000	USD
CY2021Q1	lly	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	299300000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	45500000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9154800000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46919300000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48806000000	USD
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	3250000000	USD
CY2021Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1902900000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1355300000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	435700000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	350300000	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	506600000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	119100000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	101000000.0	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	85500000	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-426100000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	302200000	USD
CY2022Q1	lly	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	153000000.0	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	102800000	USD
CY2021Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	131100000	USD
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	32600000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2499200000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1697400000	USD
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	365400000	USD
CY2021Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	300300000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	26700000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4000000.0	USD
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	14600000	USD
CY2021Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	19400000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	81400000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	284800000	USD
CY2022Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	116700000	USD
CY2021Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	291500000	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	747400000	USD
CY2022Q1	lly	Purchased In Process Research And Development PurchasedInProcessResearchAndDevelopment	491800000	USD
CY2021Q1	lly	Purchased In Process Research And Development PurchasedInProcessResearchAndDevelopment	191800000	USD
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	133400000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	21900000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1013800000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1283500000	USD
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	885500000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	774800000	USD
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	499700000	USD
CY2021Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3700000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	710100000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1500000000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-282400000	USD
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-279900000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2878300000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1058400000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33600000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-10200000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1359300000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-654700000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3818500000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3657100000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2459200000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3002400000	USD
CY2022Q1	us-gaap	Revenues Revenues	7810000000	USD
CY2021Q1	us-gaap	Revenues Revenues	6805600000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	251600000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	262600000	USD
CY2022Q1	us-gaap	Revenues Revenues	7810000000	USD
CY2021Q1	us-gaap	Revenues Revenues	6805600000	USD
CY2022Q1	us-gaap	Revenues Revenues	7810000000	USD
CY2021Q1	us-gaap	Revenues Revenues	6805600000	USD
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	165600000	USD
CY2021Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	312000000	USD
CY2022Q1	us-gaap	Severance Costs1 SeveranceCosts1	0	USD
CY2021Q1	us-gaap	Severance Costs1 SeveranceCosts1	11500000	USD
CY2022Q1	lly	Asset Impairment Charges Recoveries And Other Special Charges AssetImpairmentChargesRecoveriesAndOtherSpecialCharges	0	USD
CY2021Q1	lly	Asset Impairment Charges Recoveries And Other Special Charges AssetImpairmentChargesRecoveriesAndOtherSpecialCharges	200100000	USD
CY2022Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	0	USD
CY2021Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	211600000	USD
CY2022Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	108100000	USD
CY2022Q1	us-gaap	Maximum Remaining Maturity Of Foreign Currency Derivatives1 MaximumRemainingMaturityOfForeignCurrencyDerivatives1	P180D
CY2022Q1	us-gaap	Translation Adjustment For Net Investment Hedge Net Of Tax TranslationAdjustmentForNetInvestmentHedgeNetOfTax	4900000000	USD
CY2021Q4	us-gaap	Translation Adjustment For Net Investment Hedge Net Of Tax TranslationAdjustmentForNetInvestmentHedgeNetOfTax	5790000000	USD
CY2022Q1	lly	Description Of Derivative Activity Volume Percent DescriptionOfDerivativeActivityVolumePercent	0.14
CY2022Q1	lly	Derivative Instruments Gain Loss Recognized DerivativeInstrumentsGainLossRecognized	-6300000	USD
CY2021Q1	lly	Derivative Instruments Gain Loss Recognized DerivativeInstrumentsGainLossRecognized	-208600000	USD
CY2022Q1	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	-16500000	USD
CY2022Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments	843000000	USD
CY2022Q1	lly	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Commitments Payment Period FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommitmentsPaymentPeriod	P10Y
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	567100000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	98900000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	197700000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	110700000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	159800000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-425400000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	301500000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1300000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	9700000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	25200000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	5200000	USD
CY2022Q1	lly	Debt Securities Availableforsale Unrealized Gain Position DebtSecuritiesAvailableforsaleUnrealizedGainPosition	89500000	USD
CY2021Q4	lly	Debt Securities Availableforsale Unrealized Gain Position DebtSecuritiesAvailableforsaleUnrealizedGainPosition	250700000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	440600000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	290200000	USD
CY2022Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Other Percentage Of Nonperforming Assets AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherPercentageOfNonperformingAssets	0.97
CY2022Q1	lly	Proceedsfrom Saleof Equityand Availablefor Sale Securities ProceedsfromSaleofEquityandAvailableforSaleSecurities	35200000	USD
CY2021Q1	lly	Proceedsfrom Saleof Equityand Availablefor Sale Securities ProceedsfromSaleofEquityandAvailableforSaleSecurities	43300000	USD
CY2022Q1	lly	Availablefor Sale Securitiesand Equity Securities Fvni Realized Gain AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain	100000	USD
CY2021Q1	lly	Availablefor Sale Securitiesand Equity Securities Fvni Realized Gain AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain	1100000	USD
CY2022Q1	lly	Availableforsale Securitiesand Equity Securities Fvni Realized Loss AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss	800000	USD
CY2021Q1	lly	Availableforsale Securitiesand Equity Securities Fvni Realized Loss AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss	400000	USD
CY2022Q1	us-gaap	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized	449500000	USD
CY2021Q4	us-gaap	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized	550500000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.073
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.082
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	56500000	USD
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-61300000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	117800000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	11100000	USD
CY2021Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-89700000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	100800000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	65300000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	170300000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	84900000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	87800000	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000000.0	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	5500000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-425400000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	301500000	USD
CY2022Q1	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-93300000	USD
CY2021Q1	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-73400000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	59300000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	28500000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-350700000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	321100000	USD

Files In Submission

Name	View Source	Status
0000059478-22-000133-index-headers.html	Edgar Link	pending
0000059478-22-000133-index.html	Edgar Link	pending
0000059478-22-000133.txt	Edgar Link	pending
0000059478-22-000133-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lly-03312022x10qxexhibit311.htm	Edgar Link	pending
lly-03312022x10qxexhibit312.htm	Edgar Link	pending
lly-03312022x10qxexhibit32.htm	Edgar Link	pending
lly-20220331.htm	Edgar Link	pending
lly-20220331.xsd	Edgar Link	pending
lly-20220331_cal.xml	Edgar Link	unprocessable
lly-20220331_def.xml	Edgar Link	unprocessable
lly-20220331_htm.xml	Edgar Link	completed
lly-20220331_lab.xml	Edgar Link	unprocessable
lly-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LLY
ELI LILLY & Co Stock $lly

2022 Q1 Form 10-Q Financial Statement

#000005947822000133 Filed on April 29, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LLY ELI LILLY & Co Stock $lly

2022 Q1 Form 10-Q Financial Statement

#000005947822000133 Filed on April 29, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LLY
ELI LILLY & Co Stock $lly